Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Depreciation and Depletion: 2011-2017

Historic Depreciation and Depletion for Tenax Therapeutics (TENX) over the last 5 years, with Dec 2017 value amounting to $2,621.

  • Tenax Therapeutics' Depreciation and Depletion fell 33.68% to $2,621 in Q4 2017 from the same period last year, while for Dec 2017 it was $12,621, marking a year-over-year decrease of 33.41%. This contributed to the annual value of $7,570 for FY2023, which is 47.19% up from last year.
  • Per Tenax Therapeutics' latest filing, its Depreciation and Depletion stood at $2,621 for Q4 2017, which was down 12.63% from $3,000 recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Depreciation and Depletion ranged from a high of $23,000 in Q1 2013 and a low of $2,621 during Q4 2017.
  • For the 3-year period, Tenax Therapeutics' Depreciation and Depletion averaged around $7,219, with its median value being $5,000 (2016).
  • Data for Tenax Therapeutics' Depreciation and Depletion shows a maximum YoY plummeted of 40.91% (in 2015) over the last 5 years.
  • Over the past 5 years, Tenax Therapeutics' Depreciation and Depletion (Quarterly) stood at $23,000 in 2013, then fell by 8.70% to $21,000 in 2014, then crashed by 40.91% to $13,000 in 2015, then reached $3,952 in 2016, then tumbled by 33.68% to $2,621 in 2017.
  • Its Depreciation and Depletion stands at $2,621 for Q4 2017, versus $3,000 for Q3 2017 and $3,000 for Q2 2017.